Annual FCF:
-$117.11M-$74.04M(-171.94%)Summary
- As of today, MLTX annual free cash flow is -$117.11 million, with the most recent change of -$74.04 million (-171.94%) on December 31, 2024.
- During the last 3 years, MLTX annual free cash flow has fallen by -$81.88 million (-232.45%).
- MLTX annual free cash flow is now -36877.20% below its all-time high of -$316.70 thousand, reached on December 1, 2020.
Performance
MLTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$54.53M-$16.36M(-42.84%)Summary
- As of today, MLTX quarterly free cash flow is -$54.53 million, with the most recent change of -$16.36 million (-42.84%) on June 30, 2025.
- Over the past year, MLTX quarterly free cash flow has dropped by -$26.64 million (-95.52%).
- MLTX quarterly free cash flow is now -50484.42% below its all-time high of -$107.80 thousand, reached on March 1, 2021.
Performance
MLTX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$166.76M-$26.64M(-19.01%)Summary
- As of today, MLTX TTM free cash flow is -$166.76 million, with the most recent change of -$26.64 million (-19.01%) on June 30, 2025.
- Over the past year, MLTX TTM free cash flow has dropped by -$101.83 million (-156.83%).
- MLTX TTM free cash flow is now -52555.92% below its all-time high of -$316.70 thousand, reached on December 1, 2020.
Performance
MLTX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MLTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -171.9% | -95.5% | -156.8% |
| 3Y3 Years | -232.4% | -162.7% | -275.1% |
| 5Y5 Years | -10000.0% | - | - |
MLTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -232.4% | at low | -504.3% | at low | -296.8% | at low |
| 5Y | 5-Year | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
MLTX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$54.53M(-42.8%) | -$166.76M(-19.0%) |
| Mar 2025 | - | -$38.17M(+21.5%) | -$140.12M(-19.7%) |
| Dec 2024 | -$117.11M(-171.9%) | -$48.65M(-91.5%) | -$117.11M(-44.4%) |
| Sep 2024 | - | -$25.41M(+8.9%) | -$81.09M(-24.9%) |
| Jun 2024 | - | -$27.89M(-84.0%) | -$64.93M(-32.0%) |
| Mar 2024 | - | -$15.16M(-20.0%) | -$49.20M(-14.2%) |
| Dec 2023 | -$43.06M | -$12.63M(-36.5%) | -$43.06M(-2.5%) |
| Sep 2023 | - | -$9.25M(+23.9%) | -$42.03M(+0.2%) |
| Jun 2023 | - | -$12.16M(-34.7%) | -$42.13M(+17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$9.02M(+22.2%) | -$50.73M(+9.3%) |
| Dec 2022 | -$55.91M(-58.7%) | -$11.60M(-24.0%) | -$55.91M(-8.0%) |
| Sep 2022 | - | -$9.35M(+55.0%) | -$51.78M(-16.5%) |
| Jun 2022 | - | -$20.76M(-46.2%) | -$44.46M(+9.8%) |
| Mar 2022 | - | -$14.20M(-90.1%) | -$49.32M(-40.0%) |
| Dec 2021 | -$35.23M(>-9900.0%) | -$7.47M(-268.0%) | -$35.23M(-25.5%) |
| Sep 2021 | - | -$2.03M(+92.1%) | -$28.07M(-7.8%) |
| Jun 2021 | - | -$25.62M(>-9900.0%) | -$26.04M(-6034.7%) |
| Mar 2021 | - | -$107.80K(+66.0%) | -$424.50K(-34.0%) |
| Dec 2020 | -$316.70K | -$316.70K | -$316.70K |
FAQ
- What is MoonLake Immunotherapeutics annual free cash flow?
- What is the all-time high annual free cash flow for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual free cash flow year-on-year change?
- What is MoonLake Immunotherapeutics quarterly free cash flow?
- What is the all-time high quarterly free cash flow for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly free cash flow year-on-year change?
- What is MoonLake Immunotherapeutics TTM free cash flow?
- What is the all-time high TTM free cash flow for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM free cash flow year-on-year change?
What is MoonLake Immunotherapeutics annual free cash flow?
The current annual free cash flow of MLTX is -$117.11M
What is the all-time high annual free cash flow for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual free cash flow is -$316.70K
What is MoonLake Immunotherapeutics annual free cash flow year-on-year change?
Over the past year, MLTX annual free cash flow has changed by -$74.04M (-171.94%)
What is MoonLake Immunotherapeutics quarterly free cash flow?
The current quarterly free cash flow of MLTX is -$54.53M
What is the all-time high quarterly free cash flow for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly free cash flow is -$107.80K
What is MoonLake Immunotherapeutics quarterly free cash flow year-on-year change?
Over the past year, MLTX quarterly free cash flow has changed by -$26.64M (-95.52%)
What is MoonLake Immunotherapeutics TTM free cash flow?
The current TTM free cash flow of MLTX is -$166.76M
What is the all-time high TTM free cash flow for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM free cash flow is -$316.70K
What is MoonLake Immunotherapeutics TTM free cash flow year-on-year change?
Over the past year, MLTX TTM free cash flow has changed by -$101.83M (-156.83%)